TNFSF9 and neoplasm: In addition, CD48, CTLA4, HHLA2, TNFSF9, and TNFSF15 were elevated in high-risk group, suggesting that the high-risk group are more likely to show immunosuppressive phenotype in tumor microenvironment (Fig. 8B).